Marchex Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Marchex şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

-0.004%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-0.004%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	US$0.080
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Aug 05

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Mar 01

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

Oct 19

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Sep 14

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: MCHX şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: MCHX şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Marchex Piyasaya Karşı Temettü Getirisi

MCHX temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (MCHX)	0%
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Media)	2.6%
Analist tahmini (MCHX) (3 yıla kadar)	n/a

Önemli Temettü: MCHX şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, MCHX şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: MCHX US piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: MCHX herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Marchex Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

New major risk - Revenue and earnings growth

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2024 and First Quarter and Full Year of 2025

Third quarter 2024 earnings: EPS misses analyst expectations

Marchex Announces Additional AI Solutions to Empower Businesses

Marchex, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Consensus EPS estimates upgraded to US$0.085 loss

Second quarter 2024 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Marchex, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Chief Executive Officer recently bought US$272k worth of stock

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Full year 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Third quarter 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations

Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth

Consensus EPS estimates fall by 29%

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 66%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.1% to US$3.25

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Price target decreased to US$3.50

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Price target decreased to US$4.00

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Marchex: Hope Springs Eternal

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?

Consensus EPS estimates increase to -US$0.29

Consensus EPS estimates increase to -US$0.44

First quarter 2021 earnings released: US$1.14 loss per share (vs US$0.53 loss in 1Q 2020)

Marchex, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021

Marchex® Launches AI-powered SalesEngagement Solution

Is Marchex (NASDAQ:MCHX) Using Debt Sensibly?

How Much Of Marchex, Inc. (NASDAQ:MCHX) Do Insiders Own?